Commentary: Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
J Rare Dis Res Treat
.
2016;1(1):43-45.
Authors
Jessica Bauer
1
,
Jonas J Staudacher
1
,
Nancy L Krett
1
,
Barbara Jung
1
Affiliation
1
Department of Medicine, Division of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, Illinois, USA.
PMID:
27738666
PMCID:
PMC5058340
No abstract available
Grants and funding
R01 CA141057/CA/NCI NIH HHS/United States